Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Immunic Inc (NQ: IMUX )

1.360 -0.010 (-0.73%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 22, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 266,878
Open 1.340
Bid (Size) 1.340 (50)
Ask (Size) 1.520 (1)
Prev. Close 1.370
Today's Range 1.320 - 1.400
52wk Range 1.110 - 11.76
Shares Outstanding 26,249,439
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Immunic CEO hails "great day" after completing IMU-838 phase 2 trial enrolment
--News Direct-- 
Via News Direct
Immunic CEO hails "great day" after completing IMU-838 phase 2 trial enrolment
Immunic Inc (NASDAQ:IMUX) President and CEO Dr Daniel Vitt speaks to Thomas Warner from Proactive after the biotechnology company announced the completion of the enrolment of its phase 2 CALLIPER trial... 
Via TheNewswire.com

Performance

YTD
-2.86%
-2.86%
1 Month
-22.29%
-22.29%
3 Month
-9.33%
-9.33%
6 Month
-8.11%
-8.11%
1 Year
-57.63%
-57.63%

More News

Read More
Immunic CEO says Q2 results "couldn't be better"
Via News Direct
Immunic CEO says Q2 results "couldn't be better"
Via TheNewswire.com
Immunic Inc eyeing "big step" for multiple sclerosis patients
Via TheNewswire.com
Immunic Inc eyeing "big step" for multiple sclerosis patients
Via News Direct
Immunic Inc set to bring relief with encouraging results
Via News Direct
Immunic Inc set to bring relief with encouraging results
Via TheNewswire.com
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Recap: Immunic Q1 Earnings
Via Benzinga
Immunic IMU-856 trial data "clearly goes beyond" initial expectations
Via News Direct
Immunic IMU-856 trial data "clearly goes beyond" initial expectations
Via TheNewswire.com
Immunic gets a "positive surprise" from lead asset trial
Via TheNewswire.com
Why Is Immunic (IMUX) Stock Up 23% Today?
Via InvestorPlace
Preview: Immunic's Earnings
Via Benzinga
Immunic gets a "positive surprise" from lead asset trial
Via News Direct
Why Kura Sushi Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
After Positive Data In Ulcerative Colitis Study, Immunic Prioritizes Vidofludimus Calcium Program With One More Candidate
Via Benzinga
Why Is Nuvve (NVVE) Stock Down 14% Today?
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why Is Secoo (SECO) Stock Down 16% Today?
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
BARK And 3 Other Stocks Under $2 Insiders Are Aggressively Buying
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.